American Journal of Physical Medicine & Rehabilitation
zillman.blogspot.com     Apr 18, 2008          

mission of the American Journal of Physical Medicine & Rehabilitation is to publish articles about all aspects of PM&R and to promote excellence in education, scientific research, clinical practice, health policy, and administration. The scope of the Journal emphasizes... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

Minimizing Neurological Damage From Infant At-Birth Trauma With Moderate Whole-Body Cooling -...

medicalnewstoday.com     2 hrs ago          

Cincinnati Sub-Zero (CSZ) Medical, a division of CSZ Products, Inc. and the leader in the design and development of advanced patient temperature management solutions, today announced its inclusion in the implementation of a...                

comments

                   

Study: Greenhouse Bees Infecting Wild Bees With Pathogen

medicalnewstoday.com     2 hrs ago   2 related          

A study published in the open-access journal PLoS ONE reports an alarming spread of disease from commercial bees to wild pollinators that may explain a decline in the wild bee population. Almost 33% of the human diet is derived...                

comments

                   

FDA Grants Pediatric Exclusivity For TOPAMAX®

medicalnewstoday.com     2 hrs ago   3 related          

Ortho-McNeil Neurologics, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted pediatric exclusivity for TOPAMAX® (topiramate), based on studies...                

comments

                   

Nexavar Study Demonstrates Significant Improvement In Overall Survival In Patients With Liver Cancer

medicalnewstoday.com     2 hrs ago          

Bayer HealthCare AG and Onyx Pharmaceuticals, Inc. announced that The New England Journal of Medicine published landmark results of a Nexavar study in liver cancer. The data of the Phase III trial showed that Nexavar®...                

comments